Characteristics of erectile dysfunction in Saudi patients

International Journal of Impotence Research - Tập 16 Số 1 - Trang 13-20 - 2004
Ahmed I. El‐Sakka1
1Department of Urology, Suez Canal University, School of Medicine, Ismailia, Egypt

Tóm tắt

Từ khóa


Tài liệu tham khảo

Feldman HA et al. Impotence and its medical and psychosocial correlates: results of the Massachusetts Male Aging Study. J Urol 1994; 151: 54–61.

Statistical Abstract of the United States 1992, 112th edn. United States Bureau of Census: Washington, DC, 1992, p 19.

Krane RJ, Goldstein I, Saenz de Tejada I . Impotence. N Engl J Med 1989; 321: 1648–1659.

McKinlay JB, Longcope C, Gary A . The questionable physiologic and epidemiologic bases for a male climacteric syndrome: preliminary results from Massachusetts Male Aging Study. Maturitas 1989; 11: 103–115.

El-Sakka AI, Tayeb KA . Erectile dysfunction risk factors in non-insulin dependant diabetic saudi patients. J Urol, 2003; 169: 1043–1047.

NIH Consensus Development Panel on Impotence. Impotence. JAMA 1993; 270: 83–90.

Quam JP, Kig BF James EF, Coll P . Duplex and color Doppler sonographic evaluation of vasculogenic impotence. Am J Radiol 1989; 153: 1141–1147.

Chiou RK et al. Hemodynamic patterns of pharmacologically induced erection: evaluation by color Doppler sonography. J Urol 1998; 159: 109–112.

Udelson D et al. Axial penile buckling forces vs Rigiscan radial rigidity as a function of intracavernosal pressure: why Rigiscan does not predict functional erections in individual patients. Int J Impot Res 1999; 11: 327–337.

Martin CE . Factors affecting sexual function in 60–79 years old males. Arch Sex Behav 1981; 10: 399–420.

Virag R, Bouilly P, Frydman D . Is impotence an arterial disorder? A study of arterial risk factors in 440 impotent men. Lancet 1985; 26: 181–184.

Shabsigh R, Fishman IJ, Schum C, Duun JK . Cigarette smoking and other vascular risk factors in vasculogenic impotence. Urology 1991; 38: 227–231.

Saeed AAW, Taha AM, Al Shabri AH . Smoking habits of physicians in Riyadah, Saudi Arabia. Saudi M J 1989; 10: 508–511.

Fedele D et al. Erectile dysfunction in type 1 and type 2 diabetics in Italy Italiano Studio Deficit Erettile nei Diabetici. Int J Epidemiol 2000; 29: 524–531.

Bacchus RA, Bell JL, Madkour M, Kilshaw B . The prevalence of diabetes mellitus in male Saudi Arabs. Diabetologia 1982; 23: 330–332.

El-Sakka AI et al. Effects of diabetes on nitric oxide synthase and growth factor genes and protein expression in an animal model. Int J Impot Res 1999; 11: 123–132.

Rehman J et al. Diminished neurogenic but not pharmacological erections in the 2- to 3-month experimentally diabetic F-344 rat. Am J Physiol 1997; 272: H1960–H1971.

El-Sakka AI, Yen TS, Lin CS, Lue T . Traumatic arteriogenic erectile dysfunction: a rat model. Int J Impot Res 2001; 13: 162–171.

Goldstein I et al. Radiation-associated impotence. A clinical study of its mechanism. JAMA 1984; 17: 903–910.

Burchardt M et al. Hypertension is associated with severe erectile dysfunction. J Urol 2000; 164: 1188–1191.

Weiss RJ . Effects of antihypertensive agents on sexual function. Am Fam Physician 1991; 44: 2075–2082.

El-Hazmi MAF, Warsy AS, Al-Swailem AR . Prevalence of hypertension in adult Saudi population. Saudi Med J 1998; 19: 117–122.

Zorgniotti AW . Potency problems in cardiac patients and arteriopaths. In: Kirby RS, Carson C, Webster GD (eds). Impotence Diagnosis and Management of Male Erectile Dysfunction, Chapter 27. Butterworth Heinemann Ltd: Oxford, 1991, pp 232–236.

Morly JE et al. Relationship of penile brachial pressure index to myocardial infarction and cerebrovascular accidents in older men. Am J Med 1988; 84: 445–448.

McClure RD . Endocrine evaluation and therapy. Urol Clin North Am 1988; 15: 53–64.

Giuliano F et al. Switching from intracavernous prostaglandin E1 injections to oral sildenafil citrate in patients with erectile dysfunction: results of a multicenter European study. The Sildenafil Multicenter Study Group. J Urol 2000; 164: 708–711.

Hatzichristou DG . Sildenafil versus intracavernous injection therapy: efficacy and preference in patients on intracavernous injection for more than 1 year. J Urol 2000; 164: 1197–1200.